Skip to main content
PAINWeek 2025 Main banner
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it

Workshop

WRK-02 - (Workshop Showcase) Migraine Injection Hands-On Workshop With Live Injections

Thursday, September 4, 2025
1:40 PM - 3:00 PM PST
Location:  Castellana 1 (Level 3)

    Co-Presenter(s)

  • Paul G. Mathew, MD, DNBPAS, FAAN, FAHS

    Assistant Professor of Neurology
    Harvard Medical School/Mass General Brigham/Atrius Health
    Harvard Medical School/Mass General Brigham/Atrius Health
    Sharon, Massachusetts

  • Kimberly Sackheim, DO

    Headache and Pain Medicine Specialist
    Dr. Kimberly Sackheim, Medical Director and Owner, Spine & Pain Total Care
    NYU Langone Medical Center and Mount Sinai medical Center
    New York, New York

The 19th Annual PAINWeek Conference will feature an accredited continuing education (CE) hands-on workshop with live demonstrations for migraine injections. Attendees will work in groups with a training dummy to learn best practices for the placement and injection technique for migraine treatment. Additionally, the workshop will include a live patient demonstration to provide real-time application and learning opportunities. Expert presenters in the field of migraine and migraine injection will guide attendees through this treatment option, covering appropriate injection site selection, safety considerations, proper injection technique, and strategies for overcoming common challenges.

Participants MUST be registered for the PAINWeek Annual Conference to attend. All materials required for this workshop will be provided by PAINWeek.

Spots are limited! To secure your seat, Register Here!

If you plan to attend this workshop, it is HIGHLY recommended to also plan to attend all of the migraine-focused sessions presented by the two instructors leading up to this workshop.

This workshop is supported by an educational grant and in-kind product donation from AbbVie.

Learning Objectives:

  • Review the efficacy, effectiveness, and safety of chronic migraine injections
  • Review criteria needed for insurance approval for this procedure
  • Discuss expert recommendations for appropriate injection techniques and placement for chronic migraine
  • Demonstrate appropriate chronic migraine injection placement and technique, 155 units injected at 31 FDA approved sites, every 84 days for this treatment